Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase

Nature Cell Biology

Volumn 1, Issue 5, 1999, Pages 305-311

  Saxena, Manju ^a   Williams, Scott ^a   Taskén, Kjetil ^b   Mustelin, Tomas ^a  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; PTPN6 PROTEIN, HUMAN; PTPN7 PROTEIN, HUMAN; RECOMBINANT PROTEIN; SERINE; SIGNAL PEPTIDE;

AMINO ACID SUBSTITUTION; ARTICLE; CHEMICAL MODEL; CHEMISTRY; ENZYME SPECIFICITY; HUMAN; LEUKEMIA CELL LINE; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

ALANINE; AMINO ACID SUBSTITUTION; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JURKAT CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, CHEMICAL; MUTAGENESIS, SITE-DIRECTED; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; RECOMBINANT PROTEINS; SERINE; SHP1 PROTEIN TYROSINE PHOSPHATASE; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

EID: 0033193930     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/13024     Document Type: Article

References (48)

1. Scott, J. D. Cyclic nudeotide-dependent protein kinases. Pharmacol. Ther. 50, 123-145 (1991).
2. Skålhegg, B. S. & Taskén, K. Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Front. Biosci. [online] 2, d331-342 〈http://www.bioscience.org/〉 (1997).
3. Kammer, G. M. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 9, 222-229 (1988).
4. Ledbetter, J. A. et al. Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression. J. Immunol. 137, 3299-3305 (1986).
5. Kammer, G. M., Boehm, C. A., Rudolph, S. A. & Schnitz, L. A. Mobility of the human T lymphocyte surface molecules CD3, CD4, and CD8: regulation by a cAMP-dependent pathway. Proc. Natl Acad. Sci. USA 85, 792-796 (1988).
6. Skålhegg, B. S. et al. Cyclic AMP-dependent protein kinase type 1 mediates the inhibitory effects of 3′,5′-cyclic adenosine monophosphate on cell replication in human T lymphocytes. J. Biol. Chem. 267, 15707-15714 (1992).
7. fyn tyrosine kinase in T lymphocytes during sepsis. J. Immunol. 160, 929-935 (1998).
8. Skålhegg, B. S. et al. Location of cAMP-dependent protein kinase type I with the TCR/CD3 complex. Science 263, 84-87 (1994).
9. 2) with the antigen receptor during anti-immunoglobulin-induced B cell activation. Eur. J. Immunol. 26, 1290-1296 (1996).
10. Torgersen, K. M. et al. Selective activation of cAMP-dependent protein kinase type I inhibits rat natural killer cell cytotoxicity. J. Biol. Chem. 272, 5495-5500 (1997).
11. Whisler, R. L., Beiqing, L., Grants, I. S. & Newhouse, Y. G. Cyclic AMP modulation of human B cell proliferative responses: role of cAMP-dependent protein kinases in enhancing B cell responses to phorbol diesters and ionomycin. Cell. Immunol. 142, 398-415 (1992).
12. Kammer, G. M., Khan, I. U. & Malemud, C. J. Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. J. Clin. Invest. 94, 422-430 (1994).
13. Aandahl, E. M. et al. Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients. FASEB J. 12, 855-862 (1998).
14. Mustelin, T. et al. Lymphocyte activation: the coming of the phosphatases. Front. Biosci. [online] 3, d1060-1096 〈http://www.bioscience.org/〉 (1998).
15. Mustelin, T. et al. The next wave: protein tyrosine phosphatases enter T cell antigen receptor signaling. Cell. Signal. (in the press).
16. Zanke, B. et al. Cloning and expression of an inducible lymphoid-specific protein tyrosine phosphatase (HePTPase). Eur. J. Immunol. 22, 235-239 (1992).
17. Saxena, M., Williams, S., Gilman, J. & Mustelin, T. Negative regulation of T cell antigen receptor signaling by hematopoietic tyrosine phosphatase (HePTP). J. Biol. Chem. 273, 15340-15344 (1998).
18. Saxena, M., Williams, S., Brockdorff, J., Gilman, J. & Mustelin, T. Inhibition of T cell signaling by MAP kinase-targeted hematopoietic tyrosine phosphatase (HePTP). J. Biol. Chem. 274, 11693-11700 (1999).
19. Lombroso, P. J., Murdoch, G. & Lerner, M. Molecular characterization of a protein-tyrosine-phosphatase enriched in striatum. Proc. Natl Acad. Sci. USA 88, 7242-7246 (1991).
20. Sharma, E. & Lombroso, P. J. A neuronal protein tyrosine phosphatase induced by nerve growth factor. J. Biol. Chem. 270, 49-53 (1995).
21. Shiozuka, K. Y., Watanabe, T., Ikeda, S., Hashimoto, S. & Kawashima, H. Cloning and expression of PCPTP1 encoding protein tyrosine phosphatase. Gene 162, 279-284 (1995).
22. Ogata, M., Sawada, M., Fujino, Y. & Hamaoka, T. cDNA cloning and characterization of a novel receptor-type protein tyrosine phosphatase expressed predominantly in the brain. J. Biol. Chem. 270, 2337-2343 (1995).
23. Pulido, R., Zuñiga, A. & Ullrich, A. PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif. EMBO J.. 17, 7337-7350 (1998).
24. Sweiter, M., Berenstein, E. H., Swaim, W. D. & Siraganian, R. P. Aggregation of IgE receptors in rat basophilic leukemia 2H3 cells induce tyrosine phosphorylation of the cytosolic protein-tyrosine phosphatase HePTP. J. Biol. Chem. 270, 21902-21906 (1995).
25. Cobb, M. H. et al. Regulation of the MAP kinase cascade. Cell. Mol. Biol. Res. 40, 253-256 (1994).
26. Flint, A. J., Tiganis, T., Barford, D. & Tonks, N. K. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc. Natl Acad. Sci. USA 94, 1680-1685 (1997).
27. Chen, T., Cho, R. W., Stork, P. J. S. & Weber, M. J. Elevation of cyclic adenosine 3′,5′-monophosphate potentiates activation of mitogen-activated protein kinase by growth factors in LNCaP prostate cancer cells. Cancer Res. 59, 213-218 (1999).
28. Straus, D. B. & Weiss, A. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70, 585-593 (1992).
29. Whitmarsh, A. J., Shore, P., Sharrocks, A. D. & Davis, R. J. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269, 403-407 (1995).
30. Keyse, S. M. & Emslie, E. A. Oxidative stress and heat shock induce a human gene encoding a protein tyrosine phosphatase. Nature 359, 644-647 (1992).
31. Rohan, P. J. et al. PAC-1: a mitogen-induced nuclear protein tyrosine phosphatase. Science 259, 1763-1766 (1993).
32. Noguchi, T. et al. Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of ERP on cell growth. Mol. Cell. Biol. 13, 5195-5205 (1993).
33. Sun, H., Charles, C. H., Lau, L. F. & Tonks, N. K. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75, 487-493 (1994).
34. Muda, M. et al. MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J. Biol. Chem. 271, 4319-4326 (1996).
35. Camps, M. et al. Catalytic activation of the phosphatase MKP-3 by Erk2 mitogen-activated protein kinase. Science 280, 1262-1265 (1998).
36. Kemp, B. E. & Pearson, R. B. Protein kinase recognition sequence motifs. Trends Biochem. Sci. 15, 342-346 (1990).
37. Carton, A. & Tonks, N. K. PTP-PEST: a protein tyrosine phosphatase regulated by serine phosphorylation. EMBO J. 13, 3763-3771 (1994).
38. Zhang, S.-H., Kobayashi, R., Graves, P. R., Piwnica-Worms, H. & Tonks, N. K. Serine phosphorylation-dependent association of the Band 4.1-related protein tyrosine phosphatase PTPH1 with 14-3-3β protein. J. Biol. Chem. 272, 27281-27287 (1997).
39. Montminy, M. R. & Bilezikjian, L. M. Binding of a nuclear protein to thecydic-AMP response element of the somatostatin gene. Nature 328, 175-178 (1987).
40. Graves, L. M. et al. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc. Natl Acad. Sci. USA 90, 10300-10304 (1993).
41. Cook, S. J. & McCormick, F. Inhibition by cAMP of Ras-dependent activation of Raf. Science 262, 1069-1072 (1993).
42. von Willebrand, M. et al. Inhibition of phosphatidylinositol 3-kinase blocks TCR/CD3-induced activation of the mitogen-activated kinase Erk2. Eur. J. Biochem. 235, 828-835 (1996).
43. Hata, D. et al. Bruton's tyrosine kinase-mediated interleukin-2 gene activation in mast cells. J. Biol. Chem. 273, 10979-10987 (1998).
44. Williams, S. et al. Reconstitution of TCR-induced Erk2 kinase activation in Lck-negative JCaM1 cells by Syk, but not Zap. Eur. J. Biochem. 245, 84-90 (1997).
45. Jascur, T., Gilman, J. & Mustelin, T. Involvement of phosphatidylinositol 3-kinase in NFAT activation in T cells. J. Biol. Chem. 272, 14483-14488 (1997).
46. Luo, K., Hurley, T. R. & Sefton, B. M. Transfer of proteins to membranes facilitates both cyanogen bromide cleavage and two-dimensional proteolytic mapping. Oncogene 5, 921-923 (1990).
47. Couture, C. et al. Regulation of the Lck SH2 domain by tyrosine phosphorylation. J. Biol. Chem. 271, 24880-24884 (1996).
48. csk tyrosine kinase phosphorylates p56lck at Tyr-505 and down regulates its catalytic activity. EMBO J. 11, 2919-2924 (1992).